![Alison B. Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Alison B. Fleming currently works at Alpha-9 Oncology USA, Inc., as Director, Chief Executive & Operating Officer from 2021.
Dr. Fleming also formerly worked at Collegium Pharmaceutical, Inc., as Vice President-Product Development from 2002 to 2017.
Dr. Fleming received her doctorate degree in 2002 from Cornell University and undergraduate degree in 1997 from the University of Massachusetts.
Postes actifs de Alison B. Fleming
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Alison B. Fleming
| Sociétés | Poste | Fin |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Directeur Technique/Scientifique/R&D | 30/09/2021 |
Formation de Alison B. Fleming
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
